X4 Pharmaceuticals reports Q3 loss
X4 Pharmaceuticals reported a loss for the third quarter.
Related stories
ShaMaran Q3 Revenue More Than Doubles on Higher Oil Prices
M impact | EQUITY | Nov 09, 2026, 05:52 PM UTC
Alnylam Announces Five-Year HELIOS-B Data on AMVUTTRA
Alnylam said five-year HELIOS-B data demonstrate sustained benefit of AMVUTTRA (vutrisiran) in ATTR-CM.
L impact | EQUITY | Nov 09, 2026, 05:49 PM UTC
SoftBank Group, Grab and Petros Plan US$1 Billion AI Investment in Sarawak
SoftBank Group, Grab and Petros plan to invest US$1 billion to develop AI infrastructure in Sarawak.
M impact | EQUITY | Nov 09, 2026, 05:49 PM UTC
Nasdaq Composite Rises 628.82 Points (2.56%)
M impact | EQUITY | Nov 09, 2026, 05:45 PM UTC
S&P 500 rises 168.39 points, or 2.28%
M impact | EQUITY | Nov 09, 2026, 05:45 PM UTC
geniosAI Raises $19.1 Million in Seed and Series A Funding
FactSet, Zoom and General Catalyst participated in the funding.
M impact | EQUITY | Nov 09, 2026, 05:44 PM UTC